KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma-Reference-Cited by-同舟云学术

KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma

Published:2017-01-10 Issue:2 Volume:34 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Cicenas Jonas^ORCID,Tamosaitis Linas,Kvederaviciute Kotryna,Tarvydas Ricardas,Staniute Gintare,Kalyan Karthik,Meskinyte-Kausiliene Edita,Stankevicius Vaidotas,Valius Mindaugas

Funder

Scientific Council of Lithuania

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-016-0879-9.pdf

Reference115 articles.

1. Society AAC. American Cancer Society. Cancer Facts & Figures 2016. 2016. http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf .

2. Rojas AM, Fuentes G, Rausell A, Valencia A. The Ras protein superfamily: evolutionary tree and role of conserved amino acids. J Cell Biol. 2012;196(2):189–201. doi: 10.1083/jcb.201103008 .

3. Chang EH, Gonda MA, Ellis RW, Scolnick EM, Lowy DR. Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses. Proc Natl Acad Sci USA. 1982;79(16):4848–52.

4. Pai EF, Krengel U, Petsko GA, Goody RS, Kabsch W, Wittinghofer A. Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 a resolution: implications for the mechanism of GTP hydrolysis. EMBO J. 1990;9(8):2351–9.

5. Colicelli J. Human RAS superfamily proteins and related GTPases. Science’s STKE: signal transduction knowledge environment. 2004;2004(250):RE13. doi: 10.1126/stke.2502004re13 .

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prioritizing cervical cancer candidate genes using chaos game and fractal-based time series approach;Theory in Biosciences;2024-05-28

2. Tumor- and Fibroblast-Derived Cell-Free DNAs Differently Affect the Progression of B16 Melanoma In Vitro and In Vivo;International Journal of Molecular Sciences;2024-05-13

3. Case report: Dual dabrafenib and trametinib therapy for treating BRAF V600E mutated lung adenocarcinoma with BRCA2 germline mutation post multiline progression;Frontiers in Oncology;2024-04-23

4. Exploring the multifaceted role of RASGRP1 in disease: immune, neural, metabolic, and oncogenic perspectives;Cell Cycle;2024-03-18

5. Association between thyroid disorders and extra-thyroidal cancers, a review;Clinical and Translational Oncology;2024-03-15